Detection and quantification of tau aggregation using a membrane filter assay

Analytical Biochemistry

Volumn 373, Issue 2, 2008, Pages 330-336

  Chang, Edward ^a   Kuret, Jeff ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Aggregation; Alzheimer's disease; Filter assay; Tau

Indexed keywords

AGGLOMERATION; CHEMICAL DETECTION; FLUORINE COMPOUNDS; NEURODEGENERATIVE DISEASES; POROSITY; RECOMBINANT PROTEINS;

AGGREGATION KINETICS; ALZHEIMER'S DISEASE; ANALYTE CONCENTRATION; DETECTION AND QUANTIFICATIONS; MICROTUBULE ASSOCIATED PROTEIN; MONOMER CONCENTRATION; NON-LINEAR CORRELATIONS; POLYVINYLIDENE FLUORIDES;

CORRELATION DETECTORS;

TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; DISEASE COURSE; ENZYME ACTIVITY; MEMBRANE FILTER ASSAY; NERVE LESION; NEUROFIBRILLARY LESION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; QUANTITATIVE ASSAY; SENSITIVITY ANALYSIS;

EID: 37549071037     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.09.015     Document Type: Article

References (35)

1. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., and Hof P.R. Tau protein isoforms, phosphorylation, and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33 (2000) 95-130
2. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. (Berl) 82 (1991) 239-259
3. Ghoshal N., Garcia-Sierra F., Wuu J., Leurgans S., Bennett D.A., Berry R.W., and Binder L.I. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp. Neurol. 177 (2002) 475-493
4. Royall D.R., Palmer R., Mulroy A.R., Polk M.J., Roman G.C., David J.P., and Delacourte A. Pathological determinants of the transition to clinical dementia in Alzheimer's disease. Exp. Aging Res. 28 (2002) 143-162
5. Chirita C., Necula M., and Kuret J. Ligand-dependent inhibition and reversal of tau filament formation. Biochemistry 43 (2004) 2879-2887
6. LeVine III H. Thioflavine T interaction with synthetic Alzheimer's disease (-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
7. Friedhoff P., Schneider A., Mandelkow E.M., and Mandelkow E. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry 37 (1998) 10223-10230
8. Gamblin T.C., King M.E., Dawson H., Vitek M.P., Kuret J., Berry R.W., and Binder L.I. In vitro polymerization of tau protein monitored by laser light scattering: Method and application to the study of FTDP-17 mutants. Biochemistry 39 (2000) 6136-6144
9. Necula M., and Kuret J. A static laser light scattering assay for surfactant-induced tau fibrillization. Anal. Biochem. 333 (2004) 205-215
10. Bandyopadhyay B., Li G., Yin H., and Kuret J. Tau aggregation and toxicity in a cell culture model of tauopathy. J. Biol. Chem. 282 (2007) 16454-16464
11. Necula M., and Kuret J. Electron microscopy as a quantitative method for investigating tau fibrillization. Anal. Biochem. 329 (2004) 238-246
12. Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bates G.P., Davies S.W., Lehrach H., and Wanker E.E. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90 (1997) 549-558
13. Wanker E.E., Scherzinger E., Heiser V., Sittler A., Eickhoff H., and Lehrach H. Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol. 309 (1999) 375-386
14. Xu G., Gonzales V., and Borchelt D.R. Rapid detection of protein aggregates in the brains of Alzheimer patients and transgenic mouse models of amyloidosis. Alzheimer Dis. Assoc. Disord. 16 (2002) 191-195
15. Dou F., Netzer W.J., Tanemura K., Li F., Hartl F.U., Takashima A., Gouras G.K., Greengard P., and Xu H. Chaperones increase association of tau protein with microtubules. Proc. Natl. Acad. Sci. USA 100 (2003) 721-726
16. Pickhardt M., von Bergen M., Gazova Z., Hascher A., Biernat J., Mandelkow E.M., and Mandelkow E. Screening for inhibitors of tau polymerization. Curr. Alzheimer Res. 2 (2005) 219-226
17. Carmel G., Mager E.M., Binder L.I., and Kuret J. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271 (1996) 32789-32795
18. Binder L.I., Frankfurter A., and Rebhun L.I. The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101 (1985) 1371-1378
19. LoPresti P., Szuchet S., Papasozomenos S.C., Zinkowski R.P., and Binder L.I. Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes. Proc. Natl. Acad. Sci. USA 92 (1995) 10369-10373
20. Wolozin B.L., Pruchnicki A., Dickson D.W., and Davies P. A neuronal antigen in the brains of Alzheimer patients. Science 232 (1986) 648-650
21. Zhang J.H., Chung T.D., and Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4 (1999) 67-73
22. Goedert M., Spillantini M.G., Jakes R., Rutherford D., and Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3 (1989) 519-526
23. Chirita C.N., Congdon E.E., Yin H., and Kuret J. Triggers of full-length tau aggregation: A role for partially folded intermediates. Biochemistry 44 (2005) 5862-5872
24. King M.E., Ahuja V., Binder L.I., and Kuret J. Ligand-dependent tau filament formation: Implications for Alzheimer's disease progression. Biochemistry 38 (1999) 14851-14859
25. Greenberg S.G., and Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA 87 (1990) 5827-5831
26. Szendrei G.I., Lee V.M., and Otvos Jr. L. Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location. J. Neurosci. Res. 34 (1993) 243-249
27. Porzig R., Singer D., and Hoffmann R. Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. Biochem. Biophys. Res. Commun. 358 (2007) 644-649
28. Kuret J., Congdon E.E., Li G., Yin H., Yu X., and Zhong Q. Evaluating triggers and enhancers of tau fibrillization. Microsc. Res. Tech. 67 (2005) 141-155
29. C) not observed with recombinant PrP. J. Biol. Chem. 275 (2000) 38081-38087
30. Necula M., and Kuret J. Site-specific pseudophosphorylation modulates the rate of tau filament dissociation. FEBS Lett. 579 (2005) 1453-1457
31. Harlow E., and Lane D. Using Antibodies: A Laboratory Manual (1999), Cold Spring Harbor Laboratory Press, Cold Spring Harbor
32. Chirita C.N., Necula M., and Kuret J. Anionic micelles and vesicles induce tau fibrillization in vitro. J. Biol. Chem. 278 (2003) 25644-25650
33. Hu J.F., Matzavinos A., and Othmer H.G. A theoretical approach to actin filament dynamics. J. Stat. Phys. 128 (2007) 111-138
34. Necula M., Kayed R., Milton S., and Glabe C.G. Small molecule inhibitors of aggregation indicate that amyloid (oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 282 (2007) 10311-10324
35. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489